Literature DB >> 15921450

Molecular modeling of DNA cross-linking analogues based on the azinomycin scaffold.

Stefano Alcaro1, Francesco Ortuso, Robert S Coleman.   

Abstract

In this work, we present molecular modeling studies carried out using six DNA sequences and six azinomycin analogues, including the naturally occurring compound azinomycin B, selected on the basis of known cell cytotoxicity and structural analogies (epoxide and aziridine alkylating moieties). Among several computational methods the Stochastic Dynamics with Energy Minimization (SDEM) approach yielded results superior to the others with the natural compound (r(2) > 0.9) and was adopted for studying other DNA adducts, obtaining good correlation between the average theoretical cross-linking properties and the antitumor activity scale. As a result, some interesting SAR considerations have been highlighted and a cross-linking conformation different from that of the azinomycin was identified in a less potent, simplified analogue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921450     DOI: 10.1021/ci0496595

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  3 in total

1.  Sequence selectivity of azinomycin B in DNA alkylation and cross-linking: a QM/MM study.

Authors:  Dhurairajan Senthilnathan; Anbarasan Kalaiselvan; Ponnambalam Venuvanalingam
Journal:  J Mol Model       Date:  2012-08-24       Impact factor: 1.810

2.  Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury.

Authors:  Rajiv R Ratan; Ambreena Siddiq; Leila Aminova; Brett Langley; Stephen McConoughey; Ksenia Karpisheva; Hsin-Hwa Lee; Thomas Carmichael; Harley Kornblum; Giovanni Coppola; Daniel H Geschwind; Ahmet Hoke; Natalya Smirnova; Cameron Rink; Sashwati Roy; Chandan Sen; Michael S Beattie; Ron P Hart; Martin Grumet; Dongming Sun; Robert S Freeman; Gregg L Semenza; Irina Gazaryan
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 3.  Biosynthesis of DNA-Alkylating Antitumor Natural Products.

Authors:  Qiu-Yue Nie; Yu Hu; Xian-Feng Hou; Gong-Li Tang
Journal:  Molecules       Date:  2022-09-27       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.